eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | anaphylaxis |
| Comorbidity | C0577620|nut allergy |
| Sentences | 5 |
| PubMedID- 23386314 | In the therapeutic model, co-administration of type b odn plus peanut proteins was highly effective in reducing anaphylactic reactions in mice with established peanut allergy. |
| PubMedID- 23943347 | Scope: among food allergies, peanut allergy is frequently associated with severe anaphylactic reactions. |
| PubMedID- 24565775 | Background: peanut allergy creates the risk of life-threatening anaphylaxis that can disrupt psychosocial development and family life. |
| PubMedID- 23094689 | Results: peanut allergy cases (with or without anaphylaxis) had significantly higher ige reactivity to ara h 1-3 (peanut allergens) and gly m 5-6 (soy allergens) than asymptomatically sensitized children (p < 0.00001). |
| PubMedID- 20682004 | Background: the peak incidence of deaths from anaphylaxis associated with nut allergy occurs in teenagers and young adults. |
Page: 1